Discussion on Challenges and Countermeasures of Newly Revised Drug Administration Law to Drug Regulation

Zhu Jia, Weng Zhijie, Ruan Xiufang, Zhang Qing

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (12) : 1335-1340.

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (12) : 1335-1340. DOI: 10.16153/j.1002-7777.2019.12.001

Discussion on Challenges and Countermeasures of Newly Revised Drug Administration Law to Drug Regulation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 33(12): 1335-1340 https://doi.org/10.16153/j.1002-7777.2019.12.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/